共 50 条
- [2] Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (10): : 767 - 775
- [3] Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 890 - 897
- [7] Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial LANCET, 2013, 382 (9886): : 50 - 56
- [8] Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1694 - 1700